One of Australia’s most promising BioTechs says it will be torpedoed by a government plan to tighten innovation tax incentives and cap them after 10 years, warning it could...
Brisbane-based biotech company Vaxxas has appointed veteran pharmaceutical industry leader David Peacock as its new chief executive as it moves to commercialise its needle-free vaccination technology. Mr Peacock comes...
Promising biotech Vaxxas on Monday announced it will begin manufacturing its needle free vaccination patches in Brisbane for clinical trials after securing approval from Australian regulators. The commercialisation milestone...
NSW Department of Customer Service secretary Graeme Head will take the helm of the National Disability Insurance Agency following a national search. Mr Head, who begins his three-year term...
Brisbane BioTech Vaxxas has snared fresh US government funding to accelerate its needle free vaccination platform for COVID-19 applications, as the company courts private investors. Vaxxas on Tuesday announced it...
Brisbane-based vaccine patch company Vaxxas is developing the first room temperature-stable needleless vaccine for one of the world’s most common cold-like diseases, weeks after launching efforts to raise $100...
A Brisbane biotech that makes needle free vaccine delivery patches has been tapped by a global charity to help fight typhoid, the life-threatening disease that infects millions of people...
A multi-million-dollar manufacturing facility capable of producing needle-free vaccine patches in Queensland within the next five years has been completed by Brisbane-based biotechnology company Vaxxas. The Vaxxas Biomedical Facility,...
A project to convert turboprop-powered aircraft to electric propulsion is one of 19 projects to share in $44 million worth of grants through the latest round of the federal...